| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Common Stock | Sale | $10,796,554 | -48,128 | -0.81% | $224.33 | 5,909,074 | 22 Nov 2021 | Direct | F1, F2 |
| transaction | MEDP | Common Stock | Sale | $5,540,760 | -26,057 | -0.44% | $212.64 | 5,883,017 | 23 Nov 2021 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $219.65 to $229.19. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $221.11. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |